Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.35), $0.04 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- JPMorgan Downgrades Stellantis NV (STLA:IM) (STLA) to Neutral
- First Majestic raises 2026 output guidance after Q2 silver, gold gains
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
